| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | EVP, Chief Business Officer | $729K | -$79.2K | -9.8% | Jan 3, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|